The anti-ficolin-2 autoantibodies had a negative correlation with C3 levels, suggesting that anti-ficolin-2 autoantibodies may support complement consumption, potentially leading to hypocomplementemia, a common feature of active SLE. The gene discussed is FCN2; the disease is systemic lupus erythematosus.